Position in NTRA
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$384,373
+$130,786 QoQ
Shares Held
1,416
+11.7% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#578
of 844 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NTRA Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026VestGen Advisors, LLC holds $6,906,466 across 9 Diagnostics & Research names. NTRA ranks #7 (5.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
5,230 | $2,622,112 | |
| 2 | DHR |
Danaher Corp /De/
|
4,657 | $887,065 | |
| 3 | MEDP |
Medpace Holdings, Inc.
|
1,353 | $716,535 | |
| 4 | A |
Agilent Technologies, Inc.
|
4,357 | $578,740 | |
| 5 | IDXX |
Idexx Laboratories Inc /De
|
1,092 | $574,872 | |
| 6 | LH |
Labcorp Holdings Inc.
|
1,640 | $459,200 | |
| 7 | NTRA |
Natera, Inc.
This page
|
1,416 | $384,373 | |
| 8 | GRAL |
GRAIL, Inc.
|
5,182 | $353,775 |
All Filings in NTRA
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $384,373 | 1,416 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $253,587 | 1,268 | Shares | Sole | 2026-05-14 | |
| No filing history on record for this holder in this stock. | ||||||